Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma

Timothy M. Pawlik, Ronnie T. Poon, Eddie K. Abdalla, Juan M. Sarmiento, Iwao Ikai, Steven A. Curley, David M. Nagorney, Jacques Belghiti, Irene Oi Lin Ng, Yoshio Yamaoka, Gregory Y. Lauwers, Jean Nicolas Vauthey, M. Choti, K. Kelly

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on survival rates after resection of hepatocellular carcinoma (HCC) is controversial. The objective of this study was to determine whether serologic evidence of HBV or HCV infection ("hepatitis serology") can predict underlying liver disease, tumor factors, and survival rates in patients with HCC. Using a multicenter international database, we identified 446 patients with complete HBV and HCV serology. One hundred twenty-six patients were negative for HBV and HCV, 163 patients had HBV infection only, 79 patients had HCV infection only, and 78 patients had coinfection with HBV and HCV. Patients with hepatitis were more likely to have tumors smaller than 5 cm and bilateral HCC involvement. Hepatitis status (negative vs. HBV vs. HCV vs. coinfection with HBV and HCV) did not predict tumor grade or the presence of multiple tumor nodules. Patients with HCV or coinfection with HBV and HCV exhibited a lower incidence of vascular invasion, but worse fibrosis than patients with negative serology or HBV. The median survival rate was 47.9 months. The presence of hepatitis did not significantly affect the survival rate, but hepatic fibrosis and vascular invasion predicted a decreased survival rate. The prognosis after resection of HCC is influenced by tumor factors and liver disease, but not by HBV or HCV infection. The treatment for HCC should be dictated by the extent of underlying liver disease rather than by hepatitis serology.

Original languageEnglish (US)
Pages (from-to)794-805
Number of pages12
JournalJournal of Gastrointestinal Surgery
Volume8
Issue number7
DOIs
StatePublished - 2004

Fingerprint

Serology
Hepatitis B virus
Hepacivirus
Hepatitis
Liver Diseases
Hepatocellular Carcinoma
Virus Diseases
Neoplasms
Survival Rate
Coinfection
Blood Vessels
Fibrosis
Databases

Keywords

  • Hepatitis
  • Hepatocellular carcinoma
  • Resection

ASJC Scopus subject areas

  • Surgery

Cite this

Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. / Pawlik, Timothy M.; Poon, Ronnie T.; Abdalla, Eddie K.; Sarmiento, Juan M.; Ikai, Iwao; Curley, Steven A.; Nagorney, David M.; Belghiti, Jacques; Ng, Irene Oi Lin; Yamaoka, Yoshio; Lauwers, Gregory Y.; Vauthey, Jean Nicolas; Choti, M.; Kelly, K.

In: Journal of Gastrointestinal Surgery, Vol. 8, No. 7, 2004, p. 794-805.

Research output: Contribution to journalArticle

Pawlik, TM, Poon, RT, Abdalla, EK, Sarmiento, JM, Ikai, I, Curley, SA, Nagorney, DM, Belghiti, J, Ng, IOL, Yamaoka, Y, Lauwers, GY, Vauthey, JN, Choti, M & Kelly, K 2004, 'Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma', Journal of Gastrointestinal Surgery, vol. 8, no. 7, pp. 794-805. https://doi.org/10.1016/j.gassur.2004.06.013
Pawlik, Timothy M. ; Poon, Ronnie T. ; Abdalla, Eddie K. ; Sarmiento, Juan M. ; Ikai, Iwao ; Curley, Steven A. ; Nagorney, David M. ; Belghiti, Jacques ; Ng, Irene Oi Lin ; Yamaoka, Yoshio ; Lauwers, Gregory Y. ; Vauthey, Jean Nicolas ; Choti, M. ; Kelly, K. / Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. In: Journal of Gastrointestinal Surgery. 2004 ; Vol. 8, No. 7. pp. 794-805.
@article{34cb0a7807aa45eb903e33c263d502dd,
title = "Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma",
abstract = "The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on survival rates after resection of hepatocellular carcinoma (HCC) is controversial. The objective of this study was to determine whether serologic evidence of HBV or HCV infection ({"}hepatitis serology{"}) can predict underlying liver disease, tumor factors, and survival rates in patients with HCC. Using a multicenter international database, we identified 446 patients with complete HBV and HCV serology. One hundred twenty-six patients were negative for HBV and HCV, 163 patients had HBV infection only, 79 patients had HCV infection only, and 78 patients had coinfection with HBV and HCV. Patients with hepatitis were more likely to have tumors smaller than 5 cm and bilateral HCC involvement. Hepatitis status (negative vs. HBV vs. HCV vs. coinfection with HBV and HCV) did not predict tumor grade or the presence of multiple tumor nodules. Patients with HCV or coinfection with HBV and HCV exhibited a lower incidence of vascular invasion, but worse fibrosis than patients with negative serology or HBV. The median survival rate was 47.9 months. The presence of hepatitis did not significantly affect the survival rate, but hepatic fibrosis and vascular invasion predicted a decreased survival rate. The prognosis after resection of HCC is influenced by tumor factors and liver disease, but not by HBV or HCV infection. The treatment for HCC should be dictated by the extent of underlying liver disease rather than by hepatitis serology.",
keywords = "Hepatitis, Hepatocellular carcinoma, Resection",
author = "Pawlik, {Timothy M.} and Poon, {Ronnie T.} and Abdalla, {Eddie K.} and Sarmiento, {Juan M.} and Iwao Ikai and Curley, {Steven A.} and Nagorney, {David M.} and Jacques Belghiti and Ng, {Irene Oi Lin} and Yoshio Yamaoka and Lauwers, {Gregory Y.} and Vauthey, {Jean Nicolas} and M. Choti and K. Kelly",
year = "2004",
doi = "10.1016/j.gassur.2004.06.013",
language = "English (US)",
volume = "8",
pages = "794--805",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma

AU - Pawlik, Timothy M.

AU - Poon, Ronnie T.

AU - Abdalla, Eddie K.

AU - Sarmiento, Juan M.

AU - Ikai, Iwao

AU - Curley, Steven A.

AU - Nagorney, David M.

AU - Belghiti, Jacques

AU - Ng, Irene Oi Lin

AU - Yamaoka, Yoshio

AU - Lauwers, Gregory Y.

AU - Vauthey, Jean Nicolas

AU - Choti, M.

AU - Kelly, K.

PY - 2004

Y1 - 2004

N2 - The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on survival rates after resection of hepatocellular carcinoma (HCC) is controversial. The objective of this study was to determine whether serologic evidence of HBV or HCV infection ("hepatitis serology") can predict underlying liver disease, tumor factors, and survival rates in patients with HCC. Using a multicenter international database, we identified 446 patients with complete HBV and HCV serology. One hundred twenty-six patients were negative for HBV and HCV, 163 patients had HBV infection only, 79 patients had HCV infection only, and 78 patients had coinfection with HBV and HCV. Patients with hepatitis were more likely to have tumors smaller than 5 cm and bilateral HCC involvement. Hepatitis status (negative vs. HBV vs. HCV vs. coinfection with HBV and HCV) did not predict tumor grade or the presence of multiple tumor nodules. Patients with HCV or coinfection with HBV and HCV exhibited a lower incidence of vascular invasion, but worse fibrosis than patients with negative serology or HBV. The median survival rate was 47.9 months. The presence of hepatitis did not significantly affect the survival rate, but hepatic fibrosis and vascular invasion predicted a decreased survival rate. The prognosis after resection of HCC is influenced by tumor factors and liver disease, but not by HBV or HCV infection. The treatment for HCC should be dictated by the extent of underlying liver disease rather than by hepatitis serology.

AB - The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on survival rates after resection of hepatocellular carcinoma (HCC) is controversial. The objective of this study was to determine whether serologic evidence of HBV or HCV infection ("hepatitis serology") can predict underlying liver disease, tumor factors, and survival rates in patients with HCC. Using a multicenter international database, we identified 446 patients with complete HBV and HCV serology. One hundred twenty-six patients were negative for HBV and HCV, 163 patients had HBV infection only, 79 patients had HCV infection only, and 78 patients had coinfection with HBV and HCV. Patients with hepatitis were more likely to have tumors smaller than 5 cm and bilateral HCC involvement. Hepatitis status (negative vs. HBV vs. HCV vs. coinfection with HBV and HCV) did not predict tumor grade or the presence of multiple tumor nodules. Patients with HCV or coinfection with HBV and HCV exhibited a lower incidence of vascular invasion, but worse fibrosis than patients with negative serology or HBV. The median survival rate was 47.9 months. The presence of hepatitis did not significantly affect the survival rate, but hepatic fibrosis and vascular invasion predicted a decreased survival rate. The prognosis after resection of HCC is influenced by tumor factors and liver disease, but not by HBV or HCV infection. The treatment for HCC should be dictated by the extent of underlying liver disease rather than by hepatitis serology.

KW - Hepatitis

KW - Hepatocellular carcinoma

KW - Resection

UR - http://www.scopus.com/inward/record.url?scp=16644403674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644403674&partnerID=8YFLogxK

U2 - 10.1016/j.gassur.2004.06.013

DO - 10.1016/j.gassur.2004.06.013

M3 - Article

VL - 8

SP - 794

EP - 805

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 7

ER -